The core activity of Inflamalps SA is the development of biopharmaceutical products, particularly the discovery and development of anti-inflammatory and anti-microbial molecules for the treatment of diseases, such as dry eye in ophthalmology.
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
✓ Offered2
Development of dry-eye therapeutics
Development of INF101 for topical treatment of dry eye, including preclinical development, studies on mechanism of action, and preparation up to Phase I in Sjögren's syndrome.
Drug Discovery for antimicrobial molecules
Discovery and development of novel molecules against multidrug-resistant microbes, including screening, fractionation of extracts, and identification of potential new antibiotics.
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.